Literature DB >> 8835095

Two additional polymorphisms within the hypervariable MUC1 gene: association of alleles either side of the VNTR region.

W S Pratt1, I Islam, D M Swallow.   

Abstract

The gene MUC1 codes for a mucin-type glycoprotein and like most of the other mucin genes shows variable number tandem repeat (VNTR) polymorphism within the coding region. A polymorphism due to a G/A substitution in exon 2, responsible for a genetically determined variation in splicing of the MUC1 transcript, has also been reported (Ligtenberg et al. 1990, 1991). Here we describe the detection of this nucleotide substitution polymorphism by single stranded conformational analysis of genomic DNA and we also report a CA repeat polymorphism within intron 6 of the gene. Haplotypes were determined in a series of families and the common alleles of these two polymorphisms were found to be associated. These results support the notion that the VNTR polymorphism in the coding sequence of MUC1 is not caused by unequal reciprocal recombination at meiosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835095     DOI: 10.1111/j.1469-1809.1996.tb01168.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  7 in total

Review 1.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

2.  Hypervariability of the membrane-associated mucin and cancer marker MUC1.

Authors:  Joanna C Fowler; Ana S Teixeira; Lynne E Vinall; Dallas M Swallow
Journal:  Hum Genet       Date:  2003-08-27       Impact factor: 4.132

3.  The expression of human FUT1 in HT-29/M3 colon cancer cells instructs the glycosylation of MUC1 and MUC5AC apomucins.

Authors:  Anna López-Ferrer; Carme de Bolós
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

4.  Mucin variable number tandem repeat polymorphisms and severity of cystic fibrosis lung disease: significant association with MUC5AC.

Authors:  Xueliang Guo; Rhonda G Pace; Jaclyn R Stonebraker; Clayton W Commander; Anthony T Dang; Mitchell L Drumm; Ann Harris; Fei Zou; Dallas M Swallow; Fred A Wright; Wanda K O'Neal; Michael R Knowles
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

5.  MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study.

Authors:  Yasushi Horimasu; Nobuhisa Ishikawa; Sonosuke Tanaka; Chihiro Hirano; Hiroshi Iwamoto; Shinichiro Ohshimo; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori; Nobuoki Kohno
Journal:  BMC Cancer       Date:  2017-04-12       Impact factor: 4.430

6.  Plasma Mucin-1 (CA15-3) Levels in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations.

Authors:  Petr Vylet'al; Kendrah Kidd; Hannah C Ainsworth; Drahomíra Springer; Alena Vrbacká; Anna Přistoupilová; Rebecca P Hughey; Seth L Alper; Niall Lennon; Steven Harrison; Maegan Harden; Victoria Robins; Abbigail Taylor; Lauren Martin; Katrice Howard; Ibrahim Bitar; Carl D Langefeld; Veronika Barešová; Hana Hartmannová; Kateřina Hodaňová; Tomáš Zima; Martina Živná; Stanislav Kmoch; Anthony J Bleyer
Journal:  Am J Nephrol       Date:  2021-06-07       Impact factor: 3.754

7.  Genetic regulation of MUC1 alternative splicing in human tissues.

Authors:  W Ng; A X W Loh; A S Teixeira; S P Pereira; D M Swallow
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.